<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2500-5006</journal-id>
<journal-title><![CDATA[Revista Colombiana de Nefrología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colom. nefrol.]]></abbrev-journal-title>
<issn>2500-5006</issn>
<publisher>
<publisher-name><![CDATA[Asociación Colombiana de Nefrología e Hipertensión Arterial]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2500-50062017000200141</article-id>
<article-id pub-id-type="doi">10.22265/acnef.4.2.269</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Quality of life in incident patients vs. prevalent patients. Is there any difference in quality of life?]]></article-title>
<article-title xml:lang="es"><![CDATA[Calidad de vida en pacientes incidentes vs. prevalentes. ¿Hay diferencia en la calidad de vida?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Varela]]></surname>
<given-names><![CDATA[Diana-Cristina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Molano-González]]></surname>
<given-names><![CDATA[Nicolás]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vanegas]]></surname>
<given-names><![CDATA[Ofelia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[Konniev]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Dialy-Ser Clinical Research Department ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Bueri Stat Statistical ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="Af3">
<institution><![CDATA[,Dialy-Ser Nursing Department ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Dialy-Ser Department of Nephrology ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2017</year>
</pub-date>
<volume>4</volume>
<numero>2</numero>
<fpage>141</fpage>
<lpage>148</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S2500-50062017000200141&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S2500-50062017000200141&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S2500-50062017000200141&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Quality of life is impaired in patients with hemodialysis finding a lower quality of life in incidents patients, those who initiate or carry less than three months in renal replacement therapy, identifying common factors of elevated PTH, low rate body mass, anemia and use of catheter. Background: Chronic Kidney Disease (CKD) has increased its prevalence in recent years, from 44.7 patients per million in 1993 to 621 patients per million in 2012; patients who receive renal replacement therapy hemodialysis in Colombia have increasingly improved survival. The increase in the number of patients and the increase in the survival encourage us to improve the quality of life for dialysis years.  Methodology: The quality of life was compared by SF-36 in 154 patients with end-stage CKD on hemodialysis management, 77 incidents patients and 77 prevalent patients who are part of a renal unit in Bogotá, Colombia.  Results: All scales of quality of life in the entire population of hemodialysis patients have dropped. In the incident patients there is a lower quality of life compared to prevalent ones (p = 0.028) in this group the most relevant features were BMI &lt;31, hb &lt;11 g/dL and use of catheter, the scales of the SF-36 the most affected ones are those of physical component.  Conclusions: The quality of life of dialysis patients is affected with greater impact on the group of incident patients, the nutritional aspects should be enhanced, hematological goal and early vascular access and vascular access in this group.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La calidad de vida de los pacientes en hemodiálisis se ve afectada. Entre ellos, los pacientes incidentes (aquellos que inician o llevan menos de tres meses en la terapia de reemplazo renal) poseen menor calidad de vida, en comparación con los pacientes prevalentes, y presentan factores como: PTH elevada, bajo índice de masa corporal, anemia y uso de catéter.  Introducción: la enfermedad renal crónica (ERC) ha aumentado su prevalencia en los últimos años: ha pasado de ser padecida por 44,7 pacientes por millón en 1993, a ser padecida por 621 pacientes por millón en 2012. Los pacientes que reciben hemodiálisis de terapia de reemplazo renal en Colombia han aumentado sus posibilidades de supervivencia. El aumento del número de pacientes y el aumento de su pervivencia nos animan a mejorar la calidad de vida durante los años de diálisis.  Metodología: la calidad de vida fue comparada por SF-36 en 154 pacientes con ERC terminal en manejo de hemodiálisis, 77 pacientes incidentes y 77 pacientes prevalentes, que forman parte de una unidad renal en Bogotá, Colombia.  Resultados: se han reducido todas las escalas de calidad de vida en toda la población de pacientes en hemodiálisis. Los pacientes incidentes tienen menor calidad de vida en comparación con los prevalentes (p = 0,028). En este grupo, las características más relevantes fueron IMC &lt; 31, hb &lt; 11 g / dL y el uso de catéter. De las escalas del SF-36, los más afectados son los componentes físicos.  Conclusiones: la calidad de vida de los pacientes en diálisis se ve afectada con mayor impacto en el grupo de pacientes incidentes. Para este grupo, los aspectos nutricionales deben ser mejorados, así como el acceso vascular tipo fístula debe ser realizado pre diálisis y las meta de hemoglobina deben ser mayor de 11 g/dL.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[calidad de vida]]></kwd>
<kwd lng="en"><![CDATA[SF-36]]></kwd>
<kwd lng="en"><![CDATA[hemodiálisis]]></kwd>
<kwd lng="en"><![CDATA[enfermedades renales crónicas]]></kwd>
<kwd lng="es"><![CDATA[calidad de vida]]></kwd>
<kwd lng="es"><![CDATA[SF-36]]></kwd>
<kwd lng="es"><![CDATA[hemodiálisis]]></kwd>
<kwd lng="es"><![CDATA[enfermedades renales crónicas]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foley]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Collins]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[End-stage renal disease in the United States: an update from the United States Renal Data System]]></article-title>
<source><![CDATA[J Am Soc Nephrol]]></source>
<year>2007</year>
<volume>18</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2644-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Renal disease in Colombia]]></article-title>
<source><![CDATA[Ren Fail]]></source>
<year>2006</year>
<volume>28</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>643-7</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weiner]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Tighiouart]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Amin]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies]]></article-title>
<source><![CDATA[J Am Soc Nephrol]]></source>
<year>2004</year>
<volume>15</volume>
<page-range>1307-15</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalantar-Zadeh]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kopple]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Block]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association among SF-36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis]]></article-title>
<source><![CDATA[J Am Soc Nephrol]]></source>
<year>2001</year>
<volume>12</volume>
<page-range>2797-806</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lopes]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Bragg-Gresham]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Satayathum]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: The Dialysis Outcomes and Practice Patterns Study (DOPPS)]]></article-title>
<source><![CDATA[Am J Kidney Dis]]></source>
<year>2003</year>
<volume>41</volume>
<page-range>605-15</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lowrie]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
<name>
<surname><![CDATA[Curtin]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
<name>
<surname><![CDATA[LePain]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical outcomes study short form-36: a consistent and powerful predictor of mor bidity and mortality in dialysis patients]]></article-title>
<source><![CDATA[Am J Kidney Dis]]></source>
<year>2003</year>
<volume>41</volume>
<page-range>1286-92</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Unruh]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Benz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Greene]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study]]></article-title>
<source><![CDATA[Kidney Int]]></source>
<year>2004</year>
<volume>66</volume>
<page-range>355-66</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kimmel]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[Emont]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Newmann]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ESRD patient quality of life: symptoms, spiritual beliefs, psychosocial factors, and ethnicity]]></article-title>
<source><![CDATA[Am J Kidney Dis]]></source>
<year>2003</year>
<volume>42</volume>
<page-range>713-21</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kusek]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Greene]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cross-sectional study of health related quality of life in African Americans with chronic renal insufficiency: the African American Study of Kidney Disease and Hypertension Trial]]></article-title>
<source><![CDATA[Am J Kidney Dis]]></source>
<year>2002</year>
<volume>39</volume>
<page-range>513-24</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perlman]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Finkelstein]]></surname>
<given-names><![CDATA[FO]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study]]></article-title>
<source><![CDATA[Am J Kidney Dis]]></source>
<year>2005</year>
<volume>45</volume>
<page-range>658-66</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[YC]]></given-names>
</name>
<name>
<surname><![CDATA[Hung]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Hwang]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease]]></article-title>
<source><![CDATA[Nephrol Dial Transplant]]></source>
<year>2010</year>
<volume>25</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1621-6</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clement]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
<name>
<surname><![CDATA[Klarenbach]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tonelli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Arch Intern Med]]></source>
<year>2009</year>
<volume>169</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1104-12</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Finkelstein]]></surname>
<given-names><![CDATA[FO]]></given-names>
</name>
<name>
<surname><![CDATA[Story]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Firanek]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Health-related quality of life and hemoglobin levels in chronic kidney disease patients]]></article-title>
<source><![CDATA[Clin J Am Soc Nephrol]]></source>
<year>2009</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehrotra]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kopple]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nutritional management of maintenance dialysis patients: why aren't we doing better?]]></article-title>
<source><![CDATA[Annu Rev Nutr]]></source>
<year>2001</year>
<volume>21</volume>
<page-range>343-80</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moore]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Challenges of Nutrition Intervention for Malnourished Dialysis Patients]]></article-title>
<source><![CDATA[Journal of Infusion Nursing]]></source>
<year>2008</year>
<volume>31</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>361-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalantar-Zadeh]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Fouque]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kopple]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcome research, nutrition, and reverse epidemiology in maintenance dialysis patients]]></article-title>
<source><![CDATA[J Ren Nutr]]></source>
<year>2004</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>64-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coresh]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Longenecker]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of cardiovascular risk factors in chronic renal diseas]]></article-title>
<source><![CDATA[J Am Soc Nephrol]]></source>
<year>1998</year>
<volume>9</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S24-30</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalantar-Zadeh]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kopple]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients]]></article-title>
<source><![CDATA[Am J Kidney Dis]]></source>
<year>2001</year>
<volume>38</volume>
<page-range>1343-50</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalantar-Zadeh]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Block]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Humphreys]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients]]></article-title>
<source><![CDATA[Kidney Int]]></source>
<year>2003</year>
<volume>63</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>793-808</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
